Variant report
Variant | nsv963782 |
---|---|
Chromosome Location | chr2:234636877-234638804 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:6)
- CpG islands (count:305)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:6 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr2:234638531-234638615 | GM10266 | blood: | n/a | n/a |
2 | FOSL2 | chr2:234638767-234639039 | HepG2 | liver: | n/a | chr2:234638889-234638898 |
3 | POLR2A | chr2:234637803-234637807 | A549 | lung: | n/a | n/a |
4 | POLR2A | chr2:234637848-234637849 | A549 | lung: | n/a | n/a |
5 | POLR2A | chr2:234637826-234637834 | A549 | lung: | n/a | n/a |
6 | POLR2A | chr2:234637809-234637903 | Gliobla | brain: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:234637667-234637717 | BJ | skin: | n/a |
2 | chr2:234637306-234637356 | HIPEpiC | eye: | n/a |
3 | chr2:234638269-234638319 | NHDF-neo | bronchial: | n/a |
4 | chr2:234637253-234637303 | GM12892 | blood: | n/a |
5 | chr2:234637574-234637624 | T-47D | breast: | n/a |
6 | chr2:234637306-234637356 | PANC-1 | pancreas: | n/a |
7 | chr2:234637574-234637624 | Hepatocyte | liver: | n/a |
8 | chr2:234637667-234637717 | LNCaP | prostate: | n/a |
9 | chr2:234637253-234637303 | SK-N-SH | brain: | n/a |
10 | chr2:234637667-234637717 | HEEpiC | esophagus: | n/a |
11 | chr2:234637667-234637717 | HUVEC | blood vessel: | n/a |
12 | chr2:234637253-234637303 | HMEC | breast: | n/a |
13 | chr2:234637253-234637303 | HRE | kidney: | n/a |
14 | chr2:234637574-234637624 | HRCEpiC | kidney: | n/a |
15 | chr2:234637574-234637624 | BE2_C | brain: | n/a |
16 | chr2:234638269-234638319 | GM06990 | blood: | n/a |
17 | chr2:234637306-234637356 | Hela-S3 | cervix: | n/a |
18 | chr2:234637253-234637303 | Hela-S3 | cervix: | n/a |
19 | chr2:234637253-234637303 | HL-60 | blood: | n/a |
20 | chr2:234637667-234637717 | HCPEpiC | choroid plexus: | n/a |
21 | chr2:234638269-234638319 | HEK293 | kidney: | embryo |
22 | chr2:234637574-234637624 | HepG2 | liver: | n/a |
23 | chr2:234637306-234637356 | HAEpiC | amniotic membrane: | n/a |
24 | chr2:234638269-234638319 | A549 | lung: | n/a |
25 | chr2:234637306-234637356 | GM12892 | blood: | n/a |
26 | chr2:234637253-234637303 | K562 | blood: | n/a |
27 | chr2:234637253-234637303 | AG10803 | skin: | n/a |
28 | chr2:234638269-234638319 | HCM | heart: | n/a |
29 | chr2:234637253-234637303 | LNCaP | prostate: | n/a |
30 | chr2:234637667-234637717 | HCF | heart: | n/a |
31 | chr2:234637253-234637303 | AG04449 | skin: | fetal |
32 | chr2:234637306-234637356 | Hepatocyte | liver: | n/a |
33 | chr2:234637667-234637717 | NHDF-neo | bronchial: | n/a |
34 | chr2:234638269-234638319 | HNPCEpiC | eye: | n/a |
35 | chr2:234637306-234637356 | HRE | kidney: | n/a |
36 | chr2:234637306-234637356 | GM19239 | blood: | n/a |
37 | chr2:234637574-234637624 | LNCaP | prostate: | n/a |
38 | chr2:234637667-234637717 | SK-N-SH | brain: | n/a |
39 | chr2:234637574-234637624 | PFSK-1 | brain: | n/a |
40 | chr2:234638269-234638319 | Hepatocyte | liver: | n/a |
41 | chr2:234637253-234637303 | MCF-7 | breast: | n/a |
42 | chr2:234638269-234638319 | GM12891 | blood: | n/a |
43 | chr2:234637667-234637717 | NB4 | blood: | n/a |
44 | chr2:234637667-234637717 | AG04449 | skin: | fetal |
45 | chr2:234637253-234637303 | Jurkat | blood: | n/a |
46 | chr2:234637574-234637624 | Jurkat | blood: | n/a |
47 | chr2:234637667-234637717 | A549 | lung: | n/a |
48 | chr2:234637306-234637356 | AG09319 | gingival: | n/a |
49 | chr2:234637574-234637624 | SAEC | small airway: | n/a |
50 | chr2:234637574-234637624 | HAEpiC | amniotic membrane: | n/a |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
UGT1A8 | TF binding region |
UGT1A3 | TF binding region |
UGT1A8 | CpG island |
UGT1A3 | CpG island |
ENSG00000248114 | chromatin interactions |
ENSG00000224287 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs150082316 | chr2:234636895-234636896 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs45459598 | chr2:234636921-234636922 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs539087597 | chr2:234636953-234636954 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs558506225 | chr2:234636958-234636959 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs541948735 | chr2:234636975-234636976 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs562159767 | chr2:234636980-234636981 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs563939650 | chr2:234636999-234637000 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs2008584 | chr2:234637015-234637016 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs1983023 | chr2:234637022-234637023 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs533416663 | chr2:234637030-234637031 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs186918599 | chr2:234637060-234637061 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs563525403 | chr2:234637062-234637063 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs531471868 | chr2:234637076-234637077 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs547972941 | chr2:234637080-234637081 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs570780705 | chr2:234637105-234637106 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs554437278 | chr2:234637165-234637166 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs568098580 | chr2:234637167-234637168 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs2008595 | chr2:234637192-234637193 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs547390241 | chr2:234637193-234637194 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs190814480 | chr2:234637203-234637204 | Strong transcription Flanking Active TSS Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs61764026 | chr2:234637217-234637218 | Strong transcription Flanking Active TSS Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs183295666 | chr2:234637219-234637220 | Strong transcription Flanking Active TSS Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs45507691 | chr2:234637220-234637221 | Strong transcription Flanking Active TSS Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs28898616 | chr2:234637226-234637227 | Strong transcription Flanking Active TSS Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs553325629 | chr2:234637230-234637231 | Strong transcription Flanking Active TSS Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs535590480 | chr2:234637254-234637255 | Strong transcription Flanking Active TSS Weak transcription Enhancers | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
27 | rs371827044 | chr2:234637287-234637288 | Strong transcription Flanking Active TSS Weak transcription Enhancers | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
28 | rs187762667 | chr2:234637302-234637303 | Strong transcription Flanking Active TSS Weak transcription Enhancers | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
29 | rs541048622 | chr2:234637303-234637304 | Strong transcription Flanking Active TSS Weak transcription Enhancers | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
30 | rs557708388 | chr2:234637306-234637307 | Strong transcription Flanking Active TSS Weak transcription Enhancers | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
31 | rs577951721 | chr2:234637307-234637308 | Strong transcription Flanking Active TSS Weak transcription Enhancers | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
32 | rs543695455 | chr2:234637318-234637319 | Strong transcription Flanking Active TSS Weak transcription Enhancers | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
33 | rs370989772 | chr2:234637376-234637377 | Strong transcription Flanking Active TSS Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs191127700 | chr2:234637520-234637521 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs529466232 | chr2:234637527-234637528 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs182630542 | chr2:234637535-234637536 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs61764028 | chr2:234637545-234637546 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs45496293 | chr2:234637566-234637567 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs386656367 | chr2:234637569-234637570 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs573079837 | chr2:234637571-234637572 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs547453547 | chr2:234637573-234637574 | Strong transcription Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs545859432 | chr2:234637574-234637575 | Strong transcription Enhancers Weak transcription | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
43 | rs533311965 | chr2:234637575-234637576 | Strong transcription Enhancers Weak transcription | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
44 | rs144892248 | chr2:234637576-234637577 | Strong transcription Enhancers Weak transcription | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
45 | rs569892277 | chr2:234637577-234637578 | Strong transcription Enhancers Weak transcription | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
46 | rs535307581 | chr2:234637578-234637579 | Strong transcription Enhancers Weak transcription | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
47 | rs555509351 | chr2:234637579-234637580 | Strong transcription Enhancers Weak transcription | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
48 | rs566067568 | chr2:234637580-234637581 | Strong transcription Enhancers Weak transcription | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
49 | rs534776981 | chr2:234637581-234637582 | Strong transcription Enhancers Weak transcription | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
50 | rs557769938 | chr2:234637582-234637583 | Strong transcription Enhancers Weak transcription | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Cancer | 22429812 | CNVD |
Bladder cancer | 21909424 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Mental retardation | 20152051 | CNVD |
Cancer | 21183584 | CNVD |
Albright''s disease | 22277900 | CNVD |
Brachydactyly-Mental Retardation Syndrome | 22470819 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Autism | 18414403 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20605837 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:234620400-234659200 | Weak transcription | Colonic Mucosa | Colon |
2 | chr2:234620600-234652200 | Weak transcription | Esophagus | oesophagus |
3 | chr2:234626200-234649600 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
4 | chr2:234626600-234668400 | Weak transcription | NHEK | skin |
5 | chr2:234627600-234637200 | Weak transcription | Duodenum Mucosa | Duodenum |
6 | chr2:234634600-234639400 | Strong transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
7 | chr2:234634600-234648400 | Weak transcription | A549 | lung |
8 | chr2:234635200-234637000 | Weak transcription | Stomach Mucosa | stomach |
9 | chr2:234636000-234639000 | Strong transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
10 | chr2:234636200-234638400 | Enhancers | Fetal Intestine Small | intestine |
11 | chr2:234636600-234637200 | Enhancers | Liver | Liver |
12 | chr2:234636600-234637200 | Weak transcription | Gastric | stomach |
13 | chr2:234637000-234638200 | Enhancers | Stomach Mucosa | stomach |
14 | chr2:234637200-234637400 | Flanking Active TSS | Liver | Liver |
15 | chr2:234637200-234637600 | Enhancers | Duodenum Mucosa | Duodenum |
16 | chr2:234637200-234638000 | Enhancers | Gastric | stomach |
17 | chr2:234637400-234637800 | Enhancers | Liver | Liver |
18 | chr2:234637600-234638200 | Bivalent Enhancer | HepG2 | liver |
19 | chr2:234637800-234638600 | Flanking Active TSS | Liver | Liver |
20 | chr2:234638400-234640200 | Weak transcription | Fetal Intestine Small | intestine |
21 | chr2:234638600-234638800 | Active TSS | Liver | Liver |
22 | chr2:234638800-234639400 | Transcr. at gene 5' and 3' | Liver | Liver |